Nahdi Medical Company (TADAWUL: 4164)

Nahdi Medical Company Statistics

Total Valuation

Nahdi Medical Company has a market cap or net worth of SAR 15.26 billion. The enterprise value is 16.00 billion.

Market Cap	15.26B
Enterprise Value	16.00B

Important Dates

The next estimated earnings date is Wednesday, March 19, 2025.

Earnings Date	Mar 19, 2025
Ex-Dividend Date	Aug 12, 2024

Share Statistics

Nahdi Medical Company has 130.00 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	130.00M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.06%
Owned by Institutions (%)	3.95%
Float	47.92M

Valuation Ratios

The trailing PE ratio is 18.31 and the forward PE ratio is 17.48. Nahdi Medical Company's PEG ratio is 6.94.

PE Ratio	18.31
Forward PE	17.48
PS Ratio	1.64
PB Ratio	6.34
P/TBV Ratio	6.51
P/FCF Ratio	15.36
P/OCF Ratio	n/a
PEG Ratio	6.94

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.59, with an EV/FCF ratio of 16.11.

EV / Earnings	19.20
EV / Sales	1.72
EV / EBITDA	10.59
EV / EBIT	18.48
EV / FCF	16.11

Financial Position

The company has a current ratio of 1.49, with a Debt / Equity ratio of 0.62.

Current Ratio	1.49
Quick Ratio	0.51
Debt / Equity	0.62
Debt / EBITDA	0.98
Debt / FCF	1.49
Interest Coverage	11.54

Financial Efficiency

Return on equity (ROE) is 35.58% and return on invested capital (ROIC) is 14.89%.

Return on Equity (ROE)	35.58%
Return on Assets (ROA)	9.80%
Return on Capital (ROIC)	14.89%
Revenue Per Employee	1.50M
Profits Per Employee	134,809
Employee Count	6,182
Asset Turnover	1.68
Inventory Turnover	3.95

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -10.38% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-10.38%
50-Day Moving Average	123.32
200-Day Moving Average	132.38
Relative Strength Index (RSI)	36.52
Average Volume (20 Days)	124,628

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Nahdi Medical Company had revenue of SAR 9.30 billion and earned 833.39 million in profits. Earnings per share was 6.41.

Revenue	9.30B
Gross Profit	3.42B
Operating Income	865.68M
Pretax Income	844.85M
Net Income	833.39M
EBITDA	1.11B
EBIT	865.68M
Earnings Per Share (EPS)	6.41

Balance Sheet

The company has 747.65 million in cash and 1.48 billion in debt, giving a net cash position of -736.63 million or -5.67 per share.

Cash & Cash Equivalents	747.65M
Total Debt	1.48B
Net Cash	-736.63M
Net Cash Per Share	-5.67
Equity (Book Value)	2.41B
Book Value Per Share	18.53
Working Capital	959.23M

Cash Flow

In the last 12 months, operating cash flow was 1.35 billion and capital expenditures -354.62 million, giving a free cash flow of 993.32 million.

Operating Cash Flow	1.35B
Capital Expenditures	-354.62M
Free Cash Flow	993.32M
FCF Per Share	7.64

Margins

Gross margin is 36.76%, with operating and profit margins of 9.31% and 8.96%.

Gross Margin	36.76%
Operating Margin	9.31%
Pretax Margin	9.09%
Profit Margin	8.96%
EBITDA Margin	11.97%
EBIT Margin	9.31%
FCF Margin	10.68%

Dividends & Yields

This stock pays an annual dividend of 5.50, which amounts to a dividend yield of 4.68%.

Dividend Per Share	5.50
Dividend Yield	4.68%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	2
Payout Ratio	85.79%
Buyback Yield	n/a
Shareholder Yield	4.68%
Earnings Yield	5.46%
FCF Yield	6.51%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Nahdi Medical Company has an Altman Z-Score of 5.56.

Altman Z-Score	5.56
Piotroski F-Score	n/a